Medical Communications

Showing 15 posts of 6408 posts found.

FDA grants approval to WISE for neuromonitoring cortical strip

December 2, 2022 Medical Communications

WISE, a medical equipment manufacturer based in Italy, has obtained FDA approval for its single-use medical device WISE Cortical Strip …

Pulmonx secure Japanese approval for Zephyr Valve for COPD/emphysema

December 1, 2022 Medical Communications

Pulmonx, a US-based medical technology company, has secured approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for …

FDA approves Ferring’s first-in-class microbiota-based live biotherapeutic

December 1, 2022 Medical Communications

Switzerland-based Ferring Pharmaceuticals announced the FDA has approved its biotherapeutic REBYOTA®, indicated for the prevention of recurrence of Clostridioides difficile …

Bayer and Orion Corporation-developed prostate cancer treatment approved by NHS England and MHRA

November 28, 2022 Medical Communications

NHS England and the Medicines and Healthcare products Regulatory Agency have approved a prostate cancer treatment, developed jointly by Bayar …

Brainomix and Pixyl partner to offer multiple sclerosis treatment

November 28, 2022 Medical Communications

In a new partnership, UK-based medical software developer Brainomix will distribute Neuro.MS ‒ French medical imaging company Pixyl’s Software as …

NHS nurses strike announced for 15 and 20 December

November 25, 2022 Medical Communications

The Royal College of Nursing (RCN) has announced strikes on 15 and 20 December in a continuing pay dispute with …

NICE recommends new life-extending treatment for rare form of gastroesophageal cancer

November 25, 2022 Medical Communications

Clinical evidence shows Bristol Myers Squibb’s nivolumab, with chemotherapy, could help extend the lives of patients with untreated HER2-negative, advanced …

New malaria vaccine demonstrates high efficacy

September 9, 2022 Medical Communications

  A new malaria vaccine could be pivotal in the fight against the deadly disease. This vaccine has been developed …

Self-sterilising plastic kills viruses such as COVID-19

September 9, 2022 Medical Communications

Scientists from Queen’s University Belfast have developed a virus-killing plastic that could make it harder for bugs, such as COVID-19, …
mosquito-g4c5e34fdf_1280

GSK awarded UNICEF contract for malaria vaccine

August 19, 2022 Medical Communications

In 2020, nearly half a million children died from malaria in Africa alone, a rate of one child death per …

New COVID-19 study from The Lancet Psychiatry journal shows higher risk of brain fog

August 19, 2022 Medical Communications

The study also found that adults faced an increased risk of anxiety and depression, but this subsided within two months …
abstract-g7ff383c53_1920

Home-based brain stimulation study on stroke survivors finds mixed results

August 19, 2022 Medical Communications

26 stroke survivors were given four weeks of remotely supervised transcranial direct current stimulation (RS-tDCS) in an at-home cognitive rehabilitation …

Jazz Pharmaceuticals takes groundbreaking epilepsy drug Epidiolex for adolescents into phase III trial

August 19, 2022 Medical Communications

The phase III trials will assess Epidiolex over 14 weeks in a randomised, double-blind, placebo-controlled study, enrolling paediatric patients aged …

MHRA grants marketing authorisation for Novartis’ Pluvicto

August 12, 2022 Medical Communications

Radioligand therapy is used to treat patients with advanced prostate cancer

Bristol Myers Squibb and GentiBio in $1.9bn deal to develop inflammatory bowel disease therapies

August 12, 2022 Medical Communications

BMS will have the right to develop and advance up to three of the resulting programmes into clinical trials
The Gateway to Local Adoption Series

Latest content